Titanium dioxide (E 171) is a food additive that is widely used in foods and confectionery as a whitening agent.

On October 14, 2016, France's Ministry of Social Affairs and Health issued an instruction notice providing for the implementation of the "information systems security plan" for the health care sector.

After five lean years, transactions in the healthcare market rebounded spectacularly last year.

The French government introduced a measure that would allow pharmacists to fill prescriptions for brand-name biotech drugs with lower cost biosimilars.

This certification process will replace the current approvals given by the Minister of Health.

On August 20, the CNIL provided guidance on the measures to be taken by health researchers who modify the initial purposes for data processing (source document in French).

On July 16, the CNIL adopted five new Methods of Reference (MR-001 to MR-005) for the health care sector to simplify compliance procedures when processing personal data for health research purposes...

Reed Smith’s Global Regulatory Enforcement Law blog features a post on the recent launch of the new state portal in France.

Reed Smith’s Global Regulatory Enforcement Law blog features a post on the recent launch of the new state portal in France.

France has amended its rules on off-label use of drugs by broadening the instances in which such use can be authorized.

This tax is an attempt to tackle the increasing overweight problem. A draft decree is under preparation.

"Projet de loi Macron," a bill recently introduced by French Minister for Economic Affairs Emmanuel Macron, proposed the recognition of legal privilege for in-house lawyers in France.

On April 7, 2016, the French National Security Agency for Medicines and Health Products ("ANSM") launched a public consultation on a draft ministerial order setting out pharmacovigilance best practices.

On March 17, 2015, a new bill proposal was issued, advocating the creation of a class action procedure for the health sector.

The European Commission recently issued COVID-19-related guidance (see Jones Day Alert, March 2020), ahead of the entry into force of the new EU FDI screening mechanism in October 2020. Several member states have been tightening ...

The new Healthcare M&A 2024 guide covers over a dozen key jurisdictions and provides the latest legal information on market trends; establishing healthcare start-ups, ...

On August 15, 2024, Alvotech and Advanz Pharma announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT06, Alvotech's biosimilar of low dose (2 mg)...

French Decree n° 2017-884 of May 9, 2017, was adopted to implement certain provisions of the Legal Ordinance of June 16, 2016, with respect to biomedical research.

In France, transparency requirements are regulated by two main sets of laws: "The French Anti-Gift Law" . . .

In 2021, the French drug agency determined that the stocks of hundreds of specific pharmaceutical products must be maintained by pharmaceutical companies at a level equivalent to 4 months of coverage...